logo
11:24 Feb 25

Ind-Swift Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
144.10
+1.84 (+1.29%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Ind-Swift Laboratories Ltd. Financials

Ind-Swift Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
144.10
+1.84 (+1.29%)
11:24 Feb 25
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

71/100
Technically Bullish

Strength

10

Weakness

3

Opportunity

0

Threats

0

19.06 %

ROE %

15.54 %

ROA %

30.46

EPS

170.63

BVPS

116.45 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1038.73 1207.31 1280.9 192.02 594.46
Operating Expenses +
842.35 978.11 1026.7 237.28 594.38
Raw Material
566.06 667.92 624.39 92.01 278.09
Increase Decrease in Cost
-39.47 -12.34 37.07 7.54 0.58
Other Manufacturing Expense
84.14 111.28 100.68 0 0
Employee Cost
114.35 135.84 152.81 49.91 132.07
Miscellaneous Expenses
119.39 96.33 162.41 207.74 183.64
Operating Profit
196.38 229.2 254.2 -45.26 0.08
Other Income
42.71 33.5 45.37 42.42 64.48
Depreciation
131.04 57.36 53.3 8.15 29.94
Interest
95.53 92.17 51.1 -26.06 -22.93
Profit before tax and exceptio..
12.53 113.17 195.17 15.07 57.55
Exceptional Items
0 -26.65 386.59 215.88 210.03
PBT
12.53 86.52 581.76 230.95 -152.48
Provision for Taxation
14.68 38.69 160.31 7.27 19.07
Net Profit
-2.15 47.83 421.45 223.68 248.48
NET Profit after MI
-2.15 47.6 420.96 223.62 248.57
EPS
-0.36 8.1 71.24 32.53 36.41
Operating Profit Margin (%)
18.91 18.98 19.85 -23.57 0.01
Net Profit Margin (%)
-0.21 3.94 32.86 116.46 41.81

Ind-Swift Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: